Literature DB >> 17065674

Trends in hyperinsulinemia among nondiabetic adults in the U.S.

Chaoyang Li1, Earl S Ford, Lisa C McGuire, Ali H Mokdad, Randie R Little, Gerald M Reaven.   

Abstract

OBJECTIVE: Insulin resistance and compensatory hyperinsulinemia have been proposed as increasing risk for a variety of abnormalities and clinical syndromes, including type 2 diabetes and cardiovascular disease. Our aim was to assess the trends in the mean concentrations of fasting serum insulin and the prevalence of hyperinsulinemia among nondiabetic adults during the periods of 1988-1994 and 1999-2002 in the U.S. RESEARCH DESIGN AND METHODS: We conducted analyses of data among men and nonpregnant women without diabetes aged >/=20 years from the Third National Health and Nutrition Examination Survey (NHANES III; 1988-1994; n = 7,926) and NHANES 1999-2002 (n = 2,993). Both surveys were designed to represent the noninstitutionalized civilian U.S. population. We calculated age-adjusted mean concentrations of fasting insulin and the prevalence of hyperinsulinemia defined using the 75th percentile of fasting insulin among nondiabetic individuals as the cutoff value.
RESULTS: The geometric mean concentrations of fasting insulin increased by approximately 5% from 1988-1994 to 1999-2002 among nondiabetic adults aged >/=20 years in the U.S. Mexican-American men, men and women aged 20-39 years, and non-Hispanic white women had a greater relative increase in the mean concentrations of fasting insulin than their counterparts. The prevalence of hyperinsulinemia increased by 35.1% overall (38.3% among men and 32.1% among women).
CONCLUSIONS: In parallel with the obesity epidemic, concentrations of fasting insulin and prevalence of hyperinsulinemia have increased remarkably among nondiabetic U.S. adults.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065674     DOI: 10.2337/dc06-0289

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  50 in total

1.  Dysmetabolic Signals in "Metabolically Healthy" Obesity.

Authors:  Peter Manu; Constantin Ionescu-Tirgoviste; James Tsang; Barbara A Napolitano; Martin L Lesser; Christoph U Correll
Journal:  Obes Res Clin Pract       Date:  2012-01       Impact factor: 2.288

2.  Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.

Authors:  David C Landy; Tracie L Miller; Gabriela Lopez-Mitnik; Stuart R Lipsitz; Andrea S Hinkle; Louis S Constine; Carol A French; Amy M K Rovitelli; M Jacob Adams; Steven E Lipshultz
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

Review 3.  Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials.

Authors:  Akintunde O Akinkuolie; Julius S Ngwa; James B Meigs; Luc Djoussé
Journal:  Clin Nutr       Date:  2011-09-29       Impact factor: 7.324

4.  Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Marian L Neuhouser; Cathee Till; Alan Kristal; Phyllis Goodman; Ashraful Hoque; Elizabeth A Platz; Ann W Hsing; Demetrius Albanes; Howard L Parnes; Michael Pollak
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

5.  Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006.

Authors:  Mark D DeBoer; Lili Dong; Matthew J Gurka
Journal:  Metabolism       Date:  2011-10-13       Impact factor: 8.694

6.  Mechanisms related to NO-induced motility in differentiated rat aortic smooth muscle cells.

Authors:  Qinghua Pu; Daming Zhuang; Shalini Thakran; Aviv Hassid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

Review 7.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

8.  Uric acid and insulin sensitivity and risk of incident hypertension.

Authors:  John P Forman; Hyon Choi; Gary C Curhan
Journal:  Arch Intern Med       Date:  2009-01-26

9.  Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B.

Authors:  Daming Zhuang; Qinghua Pu; Bogdan Ceacareanu; Yingzi Chang; Madhulika Dixit; Aviv Hassid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 10.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.